NCT00764049

Single Pass Albumin Dialysis in Patients With Cirrhosis

Prospective Pilot Study Assessing Safety and Efficacy of Single Pass Albumin Dialysis in Patients With Acute on Chronic Liver Failure

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 11 (actual)
• Sponsor: Assistance Publique - Hôpitaux de Paris · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to determine whether a simplified device of albumin dialysis also has beneficial effects.

Detailed description

Albumin dialysis has beneficial effects in patients with acute on chronic liver failure. However, current devices are complex and costly. The aim of this study is to determine whether a simplified device of albumin dialysis also has beneficial effects.

Conditions

• Cirrhosis
• Acute on Chronic Hepatic Failure
• Hepatorenal Syndrome
• Encephalopathy

Interventions

Type	Name	Description
DEVICE	Single pass albumin dialysis	6 hours sessions of albumin dialysis.

Timeline

• Start date: 2009-06-01
• Primary completion: 2012-01-01
• Completion: 2012-07-01
• First posted: 2008-10-01
• Last updated: 2015-02-25

Locations

1 site across 1 country: France